Quintiles names ex-EMA lead chief of risk management
This article was originally published in Scrip
Biopharmaceutical development and commercial outsourcing service provider Quintiles has named Dr Stella Blackburn vice-president and global head of risk management for its real-world and late phase research group. Dr Blackburn will be responsible for leading the group's risk management efforts in North America, EU and Asia-Pacific. Dr Blackburn joins the North Carolina-based company from the European Medicines Agency, where most recently she was the EMA risk management development and scientific lead. In this role Dr Blackburn was responsible for designing and implementing risk management public policy and processes used throughout Europe.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.